Evolution of the population with chronic kidney disease in Spain in the context of the COVID-19 pandemic: a longitudinal retrospective study
Authors:
- Liliana Bilbie-LupchianLBLiliana Bilbie-Lupchian
- Bárbara Oliván-BlázquezBOBárbara Oliván-Blázquez
- Beatriz González-ÁlvarezBGBeatriz González-Álvarez
- Priscila Matovelle-OchoaPMPriscila Matovelle-Ochoa
- Verónica Casado-VicenteVCVerónica Casado-Vicente
- María Antonia Sánchez-CalaveraMSMaría Antonia Sánchez-Calavera
Open Access
- 5 March 2025
- journal article
- research article
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 26, e26
Abstract
Objectives: To analyze the sociodemographic characteristics and trends in clinical and analytical parameters among individuals with chronic kidney disease (CKD) in Aragon (Spain), who remain uninfected with COVID-19 during the first year of pandemic. The secondary objectives were to identify the associated comorbidities and their evolution throughout the pandemic, as well as to determine the cases that got worse and their possible relationship with the control of the main risk factors. Background: CKD is a major public health problem worldwide. Studies encompassing national, European, and global contexts, show a rise in the prevalence of CKD, with a significant decrease in life quality, high morbidity and mortality, and increased healthcare costs. In this scenario, primary care is a cornerstone for the early detection of CKD and for the management of progression factors. To date, there are few publications regarding the evolution of the CKD population throughout the pandemic that are not related to hospitalizations or complications due to COVID-19. Methods: We conducted a retrospective longitudinal study with real-world data from the population over 16 years of age registered in Aragon (Spain), collecting data from electronic health records. The variables included were sociodemographic, analytical and clinical (glomerular filtration rate, cholesterol, triglycerides, glycated haemoglobin, and blood pressure) and comorbidities (hypertension, dyslipidemia, obesity, diabetes, and smoking). The data were archived and processed using the SPSS v22.0 software package. Results: During the first six months of COVID-19 pandemic, the clinical parameters of people with CKD were poorly controlled, although there was a later improvement which could be related to the progressive recovery of health services. The glycated haemoglobin value found was low, which makes us suspect possible overtreatment. There is a high prevalence of high blood pressure, diabetes, dyslipidemia, obesity and smoking. Interventions targeting these factors could help reduce the burden of CKD.Keywords
This publication has 47 references indexed in Scilit:
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseKidney International, 2024
- Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD studyThe Lancet Regional Health - Europe, 2022
- Evaluation of Racial, Ethnic, and Socioeconomic Disparities in Initiation of Kidney Failure Treatment During the First 4 Months of the COVID-19 PandemicJAMA Network Open, 2021
- International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western EuropeKidney International Supplements, 2021
- KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney DiseaseKidney International, 2020
- Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International, 2019
- Management of Hypertension in Chronic Kidney DiseaseDrugs, 2019
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in AdultsJACC, 2018
- Oral antidiabetics use among diabetic type 2 patients with chronic kidney disease. Do nephrologists take account of recommendations?Journal of Diabetes and its Complications, 2016
- Cardiovascular Disease and Subsequent Kidney DiseaseArchives of internal medicine (1960), 2007